NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 8247
 
  
 
C07D HETEROCYCLIC COMPOUNDS 4158
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 3122
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 297
 
  
 
C07K PEPTIDES 2134
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2204
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 1137
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9034874 Carbamate/urea derivativesJul 17, 13May 19, 15[A61K, C07D, C07C]
7514446 Pyrimidine compoundsFeb 11, 04Apr 07, 09[A61K, C07D]
7049078 Apolipoprotein E polymorphism and treatment of alzheimer's diseaseJun 29, 99May 23, 06[G01N]
6673901 Artificial antibody polypeptidesJun 12, 98Jan 06, 04[C07K]
6291175 Methods for treating a neurological disease by determining BCHE genotypeJun 16, 99Sep 18, 01[C07H, A61K, C12Q, A01N]
6251587 Method for determining the prognosis of a patient with a neurological diseaseDec 16, 97Jun 26, 01[A61K, C12Q, C12P]
6022683 Methods for assessing the prognosis of a patient with a neurodegenerative diseaseDec 16, 96Feb 08, 00[C12Q]
5935781 Apolipoprotein E polymorphism and treatment of Alzheimer's diseaseFeb 21, 97Aug 10, 99[C07H]
5252575 Antiviral purine derivatives with improved gastrointestinal absorptionMay 21, 92Oct 12, 93[A61K, C07D]
5250688 Purine derivativesJan 22, 92Oct 05, 93[A61K, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
8338591 3-aryl-5,6-disubstituted pyridazinesExpiredMay 06, 05Dec 25, 12[C07D, A61P]
8129395 4,5-disubstituted-2-aryl pyrimidinesExpiredJan 26, 09Mar 06, 12[A01N, C07D]
8119665 Aryl imidazoles and related compounds as C5a receptor modulatorsExpiredMar 01, 07Feb 21, 12[A61K]
8007767 Amino methyl imidazoles and related compounds as C5a receptor modulatorsExpiredDec 22, 06Aug 30, 11[A61K]
7915288 1-aryl-4-substituted isoquinolinesExpiredMay 06, 05Mar 29, 11[A61K, C07D]
7906528 Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compoundsExpiredOct 05, 05Mar 15, 11[A61K, A01N, C07D]
2011/0039,759 Use of Secretin-Receptor Ligands in Treatment of Cystic Fibrosis (CF) and Chronic Obstructive Pulmonary Disease (COPD)AbandonedNov 01, 10Feb 17, 11[A61K, A61P, C07K]
7863454 3-substituted-6-aryl pyridinesExpiredMar 03, 08Jan 04, 11[C07D]
2010/0317,621 BETA-LACTAMASE INHIBITORSAbandonedNov 13, 08Dec 16, 10[A61K, C07F, C12N, A61P]
2010/0292,185 BETA-LACTAMASE INHIBITORSAbandonedMay 10, 10Nov 18, 10[A61K, C07F, A61P]
2010/0286,092 BETA-LACTAMASE INHIBITORSAbandonedNov 13, 08Nov 11, 10[A61K, C07F, C07D, A61P]
2010/0120,715 BETA-LACTAMASE INHIBITORSAbandonedMay 12, 09May 13, 10[A61K, C07F, A61P]
7482350 4,5-disubstituted-2-aryl pyrimidinesExpiredMay 06, 05Jan 27, 09[A01N, C07D]
7342115 3-substituted-6-aryl pyridinesExpiredNov 07, 03Mar 11, 08[C07D]
7291621 Substituted biaryl amides C5a receptor modulatorsExpiredJan 03, 06Nov 06, 07[A61K]
7271270 High affinity small molecule C5a receptor modulatorsExpiredMay 24, 04Sep 18, 07[C07D]
7186734 Aryl imidazoles and related compounds as C5a receptor modulatorsExpiredMar 28, 03Mar 06, 07[A61K]
7169775 Amino methyl imidazoles as C5a receptor modulatorsExpiredAug 21, 03Jan 30, 07[A61K]
7148225 Substituted biaryl amides as C5A receptor modulatorsExpiredNov 19, 04Dec 12, 06[A61K]
2006/0147,384 Use of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD)AbandonedMar 03, 06Jul 06, 06[A61K, A61L]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.